Distressing Symptoms, Disability, and Hospice Services at the End of Life: Prospective Cohort Study

• Autores: Thomas M. Gill, Ling Han, Linda Leo-Summers, Evelyne A. Gahbauer, Heather G. Allore
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 66, Nº. 1, 2018, págs. 41-47
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Objectives To evaluate the relationship between the presence and number of restricting symptoms and number of disabilities and subsequent admission to hospice at the end of life.

    Design Prospective cohort study.

    Setting Greater New Haven, Connecticut, from March 1998 to December 2014.

    Participants Decedents from a cohort of 754 persons aged 70 and older (N = 562).

    Measurements Hospice admissions were identified primarily from Medicare claims, and 15 restricting symptoms and disability in 13 activities were assessed during monthly interviews.

    Results During their last year of life, 244 (43.4%) participants were admitted to hospice. The median duration of hospice was 12.5 days (interquartile range 4–43 days). Although the largest increases were observed in the last 2 months of life, the prevalence of restricting symptoms and mean number of restricting symptoms and disabilities in the preceding months were high and trending upward. During a specific month, the likelihood of hospice admission increased by 66% (adjusted hazard ratio (aHR) = 1.66, 95% confidence interval (CI) = 1.30–2.12) in the setting of any restricting symptoms, by 9% (aHR = 1.09, 95% CI = 1.05–1.12) for each additional restricting symptom, and by 10% (aHR = 1.10, 95% CI = 1.05–1.14) for each additional disability. Each additional month with any restricting symptoms increased the likelihood of hospice admission by 7% (aHR = 1.07, 95% CI = 1.01–1.13).

    Conclusion Hospice services appear to be suitably targeted to older persons with the greatest needs at the end of life, although the short duration of hospice suggests that additional strategies are needed to better address the high burden of distressing symptoms and disability at the end of life.